Black Diamond Therapeutics
Price & Volume
Stats
See more52W Range | $1.19-$4.10 |
Market Cap | $227.1M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $70M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $70M |
Diluted EPS | $0.24 |
News
See moreYahoo Finance • 2 months ago
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Raymond James resumes coverage on Black Diamond stock with Outperform rating
Yahoo Finance • 3 months ago
ArriVent BioPharma stock maintains Buy rating at H.C. Wainwright on strong NSCLC trial data
About
CEO | Dr. Mark A. Velleca M.D., Ph.D. |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
